Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STABILOT: Islet Transplantation in Brittle T1D
NCT02854696Phase 3Unknown
- Sponsor
- CHU Grenoble Alpes
- Start
- Jul 2016
- Primary completion
- May 2023
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial in type 1 diabetes mellitus (T1D) (2 arms), sponsored by CHU Grenoble Alpes. Primary endpoint: Incremental cost-utility ratio at 1 year. Status: unknown.
02
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02854696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02854696.